Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 5/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 4/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 8/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL5548286 | 0.82 | ALDH1A1 (0.36) | CES2EPHX1HSD17B10 | |
| Trifluoroacetic Acid SCHEMBL5004254 | 0.77 | FUCA1 (0.42) | S1PR1S1PR3S1PR2CES2FAAH | |
| SCHEMBL2606460 | 0.76 | — | — | |
| Methane SCHEMBL1048808 | 0.74 | — | — | |
| Trifluoroacetic Acid SCHEMBL15711042 | 0.74 | FAAH (0.46) | CES2FAAHEPHX1FUCA1CES1 | |
| Trifluoroacetic Acid SCHEMBL2186699 | 0.72 | HCAR2 (0.41) | S1PR1S1PR3S1PR2CES2FAAH | |
| Trifluoroacetic Acid SCHEMBL29019087 | 0.72 | FUCA1 (0.39) | CES2FAAHEPHX1FUCA1CES1 | |
| Trifluoroacetic Acid SCHEMBL27176216 | 0.71 | EPHX1 (0.41) | S1PR1S1PR3S1PR2CES2FAAH | |
| Trifluoroacetic Acid SCHEMBL31031817 | 0.71 | FAAH (0.42) | CES2FAAHEPHX1CES1MEN1 | |
| Trifluoroacetic Acid SCHEMBL2435717 | 0.71 | CA2 (0.40) | FAAHEPHX1FUCA1CES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177533-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | Invion Limited (AU) | 2025-06-05 | — | — | US | disclosed |
| US-20250127898-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | Invion Limited (AU) | 2025-04-24 | — | — | US | disclosed |
| EP-4436973-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW Cho Group Limited (HK) | 2024-10-02 | — | — | EP | disclosed |
| EP-4436971-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW Cho Group Limited (HK) | 2024-10-02 | — | — | EP | disclosed |
| CN-118679164-A | Photodynamic therapy and diagnosis | RMW曹氏集团有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118591543-A | Photodynamic therapy and diagnosis | RMW曹氏集团有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20230365577-A1 | Photodynamic Therapy and Diagnosis | RMW CHO GROUP LIMITED (HK) | 2023-11-16 | — | — | US | disclosed |
| EP-4251627-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW Cho Group Limited (CN) | 2023-10-04 | — | — | EP | disclosed |
| CN-116724043-A | Photodynamic therapy and diagnosis | RMW曹氏集团有限公司 | 2023-09-08 | — | — | CN | disclosed |
| WO-2023094677-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW CHO GROUP LIMITED (CN) | 2023-06-01 | — | — | WO | disclosed |
| WO-2023094680-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW CHO GROUP LIMITED (CN) | 2023-06-01 | — | — | WO | disclosed |
| WO-2022112537-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW CHO GROUP LIMITED (CN) | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127898-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | PPOX, VHL, TP53 | S1PR1 2804/4885S1PR3 2110/4885S1PR2 2498/4885 |
| US-20250177533-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | PPOX, PPIF, ALAD | S1PR1 2387/4885S1PR3 1847/4885S1PR2 2116/4885 |
| US-20230365577-A1 | Photodynamic Therapy and Diagnosis | PPOX, PPIF, ALAD | S1PR1 2439/4885S1PR3 1907/4885S1PR2 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.